p(image-right). !http://newsinfo.nd.edu/assets/52531/mark_alber_comp.jpg(Mark Alber)! An interdisciplinary collaboration of six researchers, including four from Notre Dame, have received a three-year National Institutes of Health (NIH) grant to study the interplay of motility mechanisms during swarming of the bacterium _Myxococcus xanthus_. Their study is essential to understanding how millions of bacteria function in real environments. "Mark Alber":http://physics.nd.edu/people/faculty/mark-alber/, the Vincent J. Duncan Family Professor of Applied Mathematics and director of the "Center for Study of Biocomplexity":http://nd.edu/~icsb/ at the University of Notre Dame, is principal investigator of the team.

Read More about Notre Dame researchers lead collaborative team to study bacteria movement

p(image-right). !http://newsinfo.nd.edu/assets/48192/wiest_olaf_web_comp.jpg(Olaf Wiest)! NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least. But difficult doesn’t mean impossible, and "Olaf Wiest":http://newsinfo.nd.edu/for-the-media/nd-experts/faculty/olaf-wiest/, professor of chemistry and biochemistry at the University of Notre Dame, is one of a group of collaborators studying the effects of a specific molecule (JQ1) on the trigger that controls the growth of this form of cancer.

Read More about Controlling gene expression to halt cancer growth